SupplierRadar

Effepharm (Shanghai) Co., Ltd

FDA import alert and refusal historyShanghai, ChinaFEI 3013722865

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Effepharm (Shanghai) Co., Ltd.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectEffepharm (Shanghai) Co., Lt added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

As of October 26, 2026, Effepharm (Shanghai) Co., Ltd is not on any FDA import alert in SupplierRadar's records; FDA refused 1 of its shipment line on September 3, 2026, most often for not identified as a dietary supplement (DIETARYLBL).

Data from FDA public records, last checked . Request a correction

Current status

Import alerts
Not listed
Last import refusal
Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · LIST INGRE
Last warning letter
None found
Last inspection
None on record

Every FDA record for Effepharm (Shanghai) Co., Ltd

1 record, newest first. Each line links to the FDA page it came from.

2026

  1. Import refusal
    Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.LIST INGREDIETARYLBLLACKS FIRMLABELINGNUTRIT LBLEntry AEK-0890916-9
    Source

Refusal charges, in plain English

  • DIETARYLBL1 refused line

    Not identified as a dietary supplement

    The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).

  • LABELING1 refused line

    Fair Packaging and Labeling Act

    The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

  • LACKS FIRM1 refused line

    Manufacturer name and address missing

    The packaged product's label appeared not to show the name and place of business of the manufacturer, packer, or distributor.

  • LIST INGRE1 refused line

    Ingredients not listed

    The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

  • NUTRIT LBL1 refused line

    Nutrition information missing from label

    The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Effepharm (Shanghai) Co., Ltd

Is Effepharm (Shanghai) Co., Ltd on an FDA import alert?
No listing for Effepharm (Shanghai) Co., Ltd appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the China page.
Has FDA refused shipments from Effepharm (Shanghai) Co., Ltd?
Yes. FDA refused 1 shipment line from Effepharm (Shanghai) Co., Ltd on September 3, 2026. The most recent, on September 3, 2026, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as LIST INGRE (ingredients not listed).
Why did FDA refuse Effepharm (Shanghai) Co., Ltd's shipments?
The most frequent charges are DIETARYLBL (not identified as a dietary supplement, 1 line) and LABELING (fair packaging and labeling act, 1 line).
What is Effepharm (Shanghai) Co., Ltd's FEI number?
Effepharm (Shanghai) Co., Ltd's FDA Establishment Identifier (FEI) is 3013722865.

Buying from Effepharm (Shanghai) Co., Ltd?

Watch it and get the FDA record the day it changes. Free for one supplier.

Watch this supplier

Watch this supplier

Get an email when FDA publishes anything new on Effepharm (Shanghai) Co., Ltd.

Enter your work email and confirm with the link we send. Your first supplier is free, with no password and no card.

Example subjectEffepharm (Shanghai) Co., Lt added to Import Alert 16-129 (red list)

Free for one supplier. No password, no card.

SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.